Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
100 Results for "
tetrapeptide
" in MedChemExpress (MCE) Product Catalog:
Products (100)
100 Results for "tetrapeptide" in MCE Product Catalog:
Cat. No.: HY-P3882
Target:
Research Areas:
Cat. No.: HY-106154
CAS No.: 274912-87-7
Research Areas:
DTS-201 (CPI-0004) is a peptidic prodrug of Doxorubicin (HY-15142A). DTS-201, comprising the tetrapeptide portion, is cleaved by endopeptidases in the tumor environment to produce metabolites that subsequently enter the cell and are converted to active Doxorubicin. DTS-201 shows antitumoral efficacy in tumor xenograft models of prostate, breast, and lung cancer .
Cat. No.: HY-P10007
CAS No.: 159659-05-9
Synonyms: Z-GPFL-CHO
Target:
Research Areas:
Cat. No.: HY-178720
CAS No.: 2168573-03-1
Target:
Research Areas:
SHR0687 is a selective tetrapeptide kappa opioid receptor (KOR) agonist with an EC50 of 0.53 pM. SHR0687 displays high potency and selectivity over MOR and DOR, with negligible blood-brain barrier penetration. SHR0687 activates KOR specifically, leading to potential modulation of neurological pathways without significant central nervous system effects. SHR0687 can be used for the research of pain .
Cat. No.: HY-P10555
CAS No.: 90549-86-3
Target:
Research Areas:
Cat. No.: HY-129516
CAS No.: 131449-37-1
Target:
Research Areas:
A-70874 is a tyrosine-free tetrapeptide analog of cholecystokinin (30-33) (CCK-4). A-70874 is an agonist that stimulates pancreatic amylase release and a partial agonist that stimulates pancreatic phosphoinositide decomposition. A-70874 has an IC50 of 4.9 nM for the guinea pig pancreatic CCK receptor. Cholecystokinin (CCK) receptors are divided into CCK-A (digestive tract) and CCK-B (brain). A-70874 has an affinity of 1.6 μM for the CCK-B/gastrin receptor .
Cat. No.: HY-P12110
Target:
Research Areas:
Cat. No.: HY-P11427
CAS No.: 259176-74-4
Target:
Research Areas:
Cat. No.: HY-175395
Category:
Target:
Cat. No.: HY-P2674
CAS No.: 113516-56-6
Target:
Research Areas:
Cat. No.: HY-N6717S1
Cat. No.: HY-P2111
CAS No.: 121912-19-4
Target:
Research Areas:
Cat. No.: HY-182326
CAS No.: 86402-37-1
Synonyms: FR900261
Target:
Research Areas:
WF-3161 (FR900261) is a cyclic tetrapeptide antibiotic isolated from the fungus Petriella guttulata with anti-tumor activity. WF-3161 inhibits the growth of Trichophyton asteroides with an MIC of 3 μg/mL. WF-3161 is applicable to research related to P-388 leukemia .
Cat. No.: HY-P11416
CAS No.: 122207-62-9
Target:
Research Areas:
Cat. No.: HY-P992166
Synonyms: ADCE-D01 Antibody
Target:
Research Areas:
Cat. No.: HY-185832
Research Areas:
SYS6010 is an antibody-drug conjugate (ADC) targeting epidermal growth factor receptor (EGFR), which is formed by conjugating the anti-EGFR humanized IgG1 monoclonal antibody Becotatug (HY-P990049) with the topoisomerase I inhibitor JS-1 (HY-178217) via a cleavable tetrapeptide linker. SYS6010 can be used in the research of advanced solid tumors such as non-small cell lung cancer .
Cat. No.: HY-187118
CAS No.: 174308-47-5
Cat. No.: HY-P2661A
Target:
Research Areas:
Cat. No.: HY-185833
Research Areas:
ADC Control Human IgG1-JSSW-001 is the isotype control for ADC SYS6010 (HY-185832). SYS6010 is an antibody-drug conjugate (ADC) targeting epidermal growth factor receptor (EGFR), which is formed by conjugating the anti-EGFR humanized IgG1 monoclonal antibody Becotatug (HY-P990049) with the topoisomerase I inhibitor JS-1 (HY-178217) via a cleavable tetrapeptide linker. SYS6010 can be used in the research of advanced solid tumors such as non-small cell lung cancer .
Cat. No.: HY-P11904
Research Areas:
Cardiovascular Disease Metabolic Disease Inflammation/Immunology
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
